IPO Guru
GMP
Play Store
IPO Guru

IPO Listed — 02 Apr 2026

Listing Price: ₹400 (+2.04% vs ₹392)

View GMP History →
Sai Parenteral's

Sai Parenteral's IPO Review

Sai Parenteral's IPO has been reviewed by 9 analysts, and the overall consensus is Avoid — carrying a score of 39. Out of the 9 analysts who have covered this IPO, 3 recommend subscribing while 6 advise caution or avoidance — reflecting a cautious view from the analyst community.

The issue is priced in the band of ₹372-392 per share , with a minimum application size of 38 shares (minimum investment of approximately ₹14,896 at the upper band) . Subscription ran from 24 Mar 2026 to 27 Mar 2026. Scroll down for the full analyst breakdown and analyst-wise verdicts.

Table of Contents

Analyst Sentiment

Analytical Score

How it's calculated?
Avoid
39 / 100

Recommend Subscribe

Based on 9 analyst reviews

3 / 9

Higher consensus indicates broader analyst agreement.

Analyst Review

Analyst Verdict View
SBI Securities
SBI Securities
May Apply
ICICI Direct
ICICI Direct
Not Rated
DRChoksey Finserv
DRChoksey Finserv
Not Rated
Capital Market
Capital Market
Avoid -
Swastika Investmart
Swastika Investmart
Avoid
Paresh Gordhandas
Paresh Gordhandas
Avoid
Ventura Securities
Ventura Securities
Apply
GEPL Capital
GEPL Capital
Avoid
Hem Securities
Hem Securities
Apply
Suresh KP
Suresh KP
Avoid
Axis Capital
Axis Capital
Not Rated
Ashika Research
Ashika Research
Apply
Pioneer Investcorp
Pioneer Investcorp
Not Rated

Latest IPO Reviews

Bagmane Prime Office REIT
Bagmane Prime Office REIT Strong Apply
100

Score
OnEMI Technology Solutions (KISSHT)
OnEMI Technology Solutions (KISSHT) Apply
76

Score
Citius Transnet Investment Trust InvIT
Citius Transnet Investment Trust InvIT Strong Apply
100

Score
Property Share Investment Trust
Property Share Investment Trust No Rating

Frequently Asked Questions

Should I apply for Sai Parenteral's IPO?

Based on analyst coverage tracked on this page, the overall verdict for Sai Parenteral's IPO is Avoid. Out of 9 analysts who have reviewed this IPO, 3 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 39 mean for Sai Parenteral's IPO?

The score of 39 is an aggregate of all analyst ratings tracked for Sai Parenteral's IPO. A score in this range signals that most analysts are advising caution or outright avoidance. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Sai Parenteral's IPO?

Sai Parenteral's IPO listed on April 2, 2026 at ₹400 , against the issue price of ₹392 — a gain of +2.04% (₹8 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Sai Parenteral's IPO?

Sai Parenteral's IPO was priced at ₹372-392 per share. The minimum lot size is 38 shares, making the minimum investment approximately ₹14,896 at the upper end of the price band. Subscription ran from 24 Mar 2026 to 27 Mar 2026.

Explore Sai Parenteral's IPO Further

Track every stage of this IPO:

📈
GMP Today
Live grey market premium
 📊
Subscription Status
Real-time bidding data
 📋
Allotment Status
Check if you got shares

Discussion 0

💡
Commenting as
Markdown supported: **bold**, _italics_

No comments yet

Be the first to share your thoughts!

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.